NASDAQ: DRIO - DarioHealth Corp.

Rentabilité sur six mois: -41.1%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions DarioHealth Corp.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise DarioHealth Corp.

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Move, which helps to prevent and treat the most common MSK conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; Dario One, a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system.

plus de détails
It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions, including live clinical coaching, content, automated journeys, hardware, and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2014-10-06
ISIN US23725P2092
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.dariohealth.com
Цена ао 1.52
Changement de prix par jour: +0.2307% (0.6934)
Changement de prix par semaine: -13.13% (0.8)
Changement de prix par mois: -3.5% (0.7202)
Changement de prix sur 3 mois: -34.74% (1.065)
Changement de prix sur six mois: -41.1% (1.18)
Changement de prix par an: -59.59% (1.72)
Evolution du prix sur 3 ans: -94.72% (13.16)
Evolution du prix sur 5 ans: -82.18% (3.9)
Evolution des prix sur 10 ans: 0% (0.695)
Evolution des prix depuis le début de l'année: -24.46% (0.92)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 2.33 6
P/BV 0.8149 9
P/E 0 0
EV/EBITDA -0.7835 0
Total: 5.63

Efficacité

Nom Signification Grade
ROA, % -56.92 0
ROE, % -94.35 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.5637 10
Total: 8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 167.79 10
Rentabilité Ebitda, % 210.73 10
Rentabilité EPS, % -73.28 0
Total: 7.8
Plus de détails

Établissements Volume Partager, %
Nantahala Capital Management, LLC 4673506 15.87
Appian Way Asset Management LP 1322444 4.49
Y.D. More Investments Ltd 1288518 4.38
Phoenix Holdings Ltd. 1180813 4.01
Clal Insurance Enterprises Holdings Ltd 875964 2.98
Vanguard Group Inc 363042 1.23
Geode Capital Management, LLC 270573 0.92
Clarity Capital Partners LLC 170426 0.58
Blackrock Inc. 112619 0.38
LPL Financial LLC 109901 0.37

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
iShares Micro-Cap ETF 0.00664 17.09 1.54048



Superviseur Titre d'emploi Paiement Année de naissance
Mr. Erez Raphael CEO & Director 722.19k 1973 (52 année)
Dov Oppenheim Co-Founder & Production Chief N/A
Josh Fischer Senior Vice President of Operations & Compliance N/A
Claudia Levi Content & Communications Manager N/A
Mr. Jean Christophe Muyl Head of Commercialization North America N/A
Mr. Tomer Ben-Kiki Chief Technology Officer N/A 1971 (54 année)
Limor Drezner Chief People Officer N/A
Mr. Zvi Ben David CPA CFO, Treasurer & Secretary 342.58k 1961 (64 année)
Kat Parrella Investor Relations Manager
Ms. Mona Dean Chief Compliance Officer

Adresse: United States, New York. NY, 18 West 18th Street - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.dariohealth.com